Paclirich drug has the main ingredient is Paclitaxel, is prepared in the form of a concentrated solution for injection and packed in a box of 1 bottle of 17ml. This drug belongs to the group of anti-cancer drugs and acts on the immune system. The following is information about the uses, dosage and precautions when using Paclirich.

Aspaxel is a drug indicated in the treatment of ovarian cancer, breast cancer, and lung cancer. Below is all the information about the uses of Aspaxel, as well as how to use it, and the notes when using it that patients need to know when prescribed to use the drug effectively and safely.

Paclitaxel is an agent that inhibits chromatin spindle reticulum breakdown, preventing untwisting, causing abnormal formation of groups or bundles of microscopic reticulum during the cell cycle. Paclitaxel is the active ingredient in Pataxel. What does Pataxel do?

Kunitaxel drug is prepared in the form of an injection solution with the main ingredient in the drug is Paclitaxel 100mg/16.67ml. So what does Kunitaxel drug work and how to use it, let's find out through the article below.

Paclitaxel is an anti-cancer agent, including ovarian cancer, breast cancer or non-small cell lung cancer. This active ingredient is present in the product with the trade name Hepargitol. So what should be noted when using Hepargitol?

Paxus PM is an antineoplastic agent with a mandatory prescription by a specialist, commonly prescribed in metastatic breast cancers. So what does Paxus pm do, let's find out through the article below.

Breast cancer is a type of cancer with a 5-year survival rate of up to 80%, which has become quite common in women if diagnosed early and intervened at the right time. Along with increasing the survival rate, improving the quality of life of women after mastectomy is equally important.

Analytical results from the RAINBOW study provided a regimen of ramucirumab and paclitaxel for patients with gastric/gastroesophageal adenocarcinoma. This is considered a new advancement in the treatment of advanced gastric/gastro-oesophageal cancer.

Vinmec Times City is one of the first medical facilities in Vietnam to offer the treatment regimen Ramucirumab combined with Paclitaxel for patients with gastric adenocarcinoma/esophagogastric junction. Initial results give good response, few side effects, suitable for elderly patients, poor health, have failed with other chemotherapy regimens.